Skip to main content
Toggle Menu of ADA WebSites
ADA Websites
Commissions
Toggle Member Links
Toggle Menu
e-mail Print Share
Evidence-based dental management in the new era of sickle cell disease (September 2020 Article 3)
CE Credit(s):
1
Member Price:
$5.00
Retail Price:
$40.00
Description
Open Tabs
Description:

JADA September 2020

Background. Sickle cell disease (SCD) is an emerging global health issue with rapid progress in therapy especially since 2017. However, systematic reviews found no clinical trials on dental treatment of SCD.

Key Words. Sickle cell; systemic health; evidence-based dentistry; caries risk; malocclusion; pulp necrosis; ischemia; osteomyelitis; mental nerve neuropathy; guidelines.

Related Courses:
Web Test Course Details
More from the ADA: